Abiopharma

🔍 Landman Yoav (Executive)

Company: JFrog Ltd (FROG)

Report Date: 2026-08-13

Detailed Transactions and Holdings:

• Sold 1,900 shares of Ordinary Shares at $86.63 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,491,438.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 3,400 shares of Ordinary Shares at $87.61 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,488,038.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 10,198 shares of Ordinary Shares at $88.45 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,477,840.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 1,100 shares of Ordinary Shares at $89.37 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,476,740.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 11,698 shares of Ordinary Shares at $90.49 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,465,042.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 2,600 shares of Ordinary Shares at $91.36 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,462,442.00 | transaction_form_type: 4 | Footnotes: F1, F7
• Sold 1,800 shares of Ordinary Shares at $92.64 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,460,642.00 | transaction_form_type: 4 | Footnotes: F1, F8
• Sold 4,000 shares of Ordinary Shares at $93.8 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,456,642.00 | transaction_form_type: 4 | Footnotes: F1, F9
• Sold 8,277 shares of Ordinary Shares at $94.88 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,448,365.00 | transaction_form_type: 4 | Footnotes: F1, F10
• Sold 27 shares of Ordinary Shares at $95.29 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,448,338.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 1, 2025.
• F2: This transaction was executed in multiple trades at prices ranging from $85.98 to $86.97. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F3: This transaction was executed in multiple trades at prices ranging from $86.98 to $87.96. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F4: This transaction was executed in multiple trades at prices ranging from $87.98 to $88.96. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F5: This transaction was executed in multiple trades at prices ranging from $89.04 to $89.87. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F6: This transaction was executed in multiple trades at prices ranging from $90.06 to $90.97. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F7: This transaction was executed in multiple trades at prices ranging from $91.15 to $91.99. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F8: This transaction was executed in multiple trades at prices ranging from $92.18 to $93.12. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F9: This transaction was executed in multiple trades at prices ranging from $93.21 to $94.13. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F10: This transaction was executed in multiple trades at prices ranging from $94.24 to $95.20. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.